HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Mangalam Drugs & Organics Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 47 filings·Updated 17 Aug 2026
Showing 10 of 47 filings.
17 Aug 20261 filing
Others

Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default

Filed 16:39View Source
13 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026

Filed 16:45View Source
12 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Mangalam Drugs approves Q1 FY27 unaudited results and five-year audit appointments

Financial results

  • Unaudited standalone and consolidated results for quarter ended 30 June 2026 approved.

Auditor appointments

  • Statutory auditors SN. Nanda & Co appointed for five years from FY2026-27, subject to AGM.
  • Secretarial auditor M/s L.N. Joshi & Co appointed for five years from FY2026-27, subject to AGM.

Auditor opinions / compliance

  • Standalone Limited Review Reports: no modified opinion.
  • Consolidated Limited Review: no material misstatement identified.

Shareholder approvals

  • Appointments to be ratified by shareholders at the ensuing AGM.

Other disclosures

  • Board disclosed no other material actions at this meeting.
Filed 17:16View Source
6 Aug 20261 filing
Company UpdateGeneral

Mangalam Drugs & Organics Announces Resignation of Secretarial Auditor Effective 4 August 2026

Resignation of Secretarial Auditor

  • Secretarial Auditor M/s Ragini Chokshi & Co. has resigned, effective 04 August 2026.
  • Reason: pre-occupancy with professional commitments.
  • Date of resignation: 04 August 2026.
  • Resignation letter from Ragini Chokshi & Co enclosed.
  • Partner Abhishek Shukla also resigns as Secretarial Auditor, effective 04 August 2026.
Filed 17:11View Source
16 Jul 20261 filing
Others

Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III

Filed 18:04View Source
15 Jul 20261 filing
Others

Intimation of subsequent default made by Company under Para A sub-Paragraph 6 of Schedule III

Filed 17:40View Source
13 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing, listing, and ownership updates under Reg 74(5)

Dematerialisation processing and ownership updates

  • Dematerialisation requests processed; securities listed on the stock exchanges where existing securities are listed.
  • Certificates received for dematerialisation were confirmed/rejected and mutilated/cancelled after verification.
  • The registered owner was updated to the depository in records within prescribed timelines.
Filed 16:33View Source
16 May 20261 filing
Others

Intimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default

Filed 14:47View Source
17 Apr 20262 filings
Company UpdateChange in Management

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Change in Management

Company Secretary resignation

  • Ms. Anuradha Pandey resigned as Company Secretary and Compliance Officer.
  • Resignation effective 29 March 2026; last working day same date.
  • Reason: pursuing opportunities outside the company and career growth.
  • She stated the decision was not easy and thanked the company.
  • No other material reasons for resignation were stated.
Filed 13:02View Source
Company UpdateResignation of Company Secretary / Compliance Officer

Additional details required for Corporate Announcement under Regulation 30 of SEBI(LODR) Regulations, 2015 read with schedule III, Part A, Para A of 7 & 7(C) for submission of resignation ....

Filed 12:54View Source
Showing 10 of 47 filings